New Drug Target for Neurodegenerative Disease?
Researchers in California may have discovered new drug targets to treat an incurable hereditary disease that leads to loss of motor coordination, dementia and death.
Researchers in California may have discovered new drug targets to treat an incurable hereditary disease that leads to loss of motor coordination, dementia and death.
Researchers at the University of California San Diego and GlySens Inc. are developing an implantable wireless sensor to continuously monitor blood sugar in diabetes patients, Reuters reports.
Seaside Therapeutics reported encouraging results from the largest randomized study conducted to date in patients with Fragile X syndrome.
The information could allow researchers to observe cellular changes as a patient undergoes cancer treatment, and could aid in the development of new molecular therapeutics for diseases such as cancer.
An experimental drug from Nektar Therapeutics was able to shrink tumors and reduce a cancer biomarker in women with advanced ovarian cancer in a mid-stage study.
A disease that affects a significant number of Americans, that requires extensive and often frustrating lifestyle modifications, and that has no approved pharmaceutical treatment: It’s an enticing opportunity for drug companies.
A large-scale study funded by the National Institutes of Health found that both blood sugar control and a combination of cholesterol-lowering lipid drugs were effective in slowing the progression of diabetic retinopathy.
Surgical robots were once considered a fantastical invention of sci-fi authors. But the future, as they say, is now.
The technology company has developed CaseReader, a turnkey software solution designed to help radiologists conduct faster, more accurate analyses.
Healthcare IT has the potential to improve operational efficiency and lower medical costs—huge potential benefits in the era of healthcare reform.
Copyright © 2026 | WordPress Theme by MH Themes